Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study

ObjectiveTo observe the efficacy of TKI inhibitor combined with PD-1 treatment in patients with early recurrence after radical resection of HCC, and to analyze the factors that affect the efficacy.MethodsThe baseline demographic and clinical data of 58 patients with early recurrence after radical re...

Full description

Bibliographic Details
Main Authors: Zixiong Li, Ning Han, Xueying Ren, Yuanjing Zhang, Xiaoyuan Chu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
locoregional therapies
PD-1
recurrence
systemic therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.833884/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.833884/full

Similar Items